124
Participants
Start Date
May 4, 2018
Primary Completion Date
August 18, 2020
Study Completion Date
November 10, 2021
¹³C-Methacetin Breath Test
A breath analyzer will be used to measure changes in 12C (carbon 12) to 13C (carbon 13) ratio as a result of metabolism of the Methacetin substrate before and after treatment.
BMS-986036
Investigational drug for NASH treatment in Main BMS protocol
BreathID MCS device
The BreathID MCS device is a breath analyzer specifically used for measuring changes in the ratio of 13CO2 and 12CO2 isotopes of carbon dioxide. The device is connected to the subject via a nasal cannula and breath is passively collected before and after ingestion of labelled 13C- Methacetin substrate.
Spring Gastroenterology, Humble
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Meridian Bioscience, Inc.
INDUSTRY